Shingles Vaccine Crisis: NHS Warns of Rising Risks
Health officials are raising urgent concerns as new data reveals a worrying decline in shingles vaccine uptake across England. The potentially debilitating virus, which affects nerves and skin, poses a growing threat to vulnerable groups who are missing crucial NHS jabs.
Who's Most at Risk?
The shingles vaccine is currently offered to:
- People turning 65
- Those aged 70-79
- Individuals with weakened immune systems
Yet thousands in these high-risk categories are failing to get protected, with experts warning the consequences could be severe.
Why Vaccination Rates Are Falling
Several factors are contributing to the decline:
- Post-pandemic backlog: Many routine vaccinations were delayed during COVID-19 disruptions
- Public awareness gaps: Misunderstanding about shingles risks and vaccine effectiveness
- Access challenges: Some patients report difficulties booking appointments
Dr. Sarah Wilkinson, a leading GP, told reporters: "We're seeing preventable cases of shingles that cause months of pain. It's heartbreaking when a simple jab could stop this suffering."
What You Need to Know About Shingles
Shingles, caused by the same virus as chickenpox, can lead to:
- Painful rashes lasting weeks
- Long-term nerve damage (postherpetic neuralgia)
- Vision loss if affecting the eye
- Increased stroke risk in severe cases
The NHS urges eligible individuals to check their vaccination status immediately. One dose provides about 70% protection for at least seven years – potentially preventing years of discomfort.
